Personalis to Participate in Upcoming Investor Events

FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced today that its management team will be participating in the following investor events:

• Craig Hallum 23rd Annual Institutional Investor Conference on May 28, 2026 at the Depot Renaissance Hotel in Minneapolis, MN.
• Jefferies 2026 Global Healthcare Conference on June 3, 2026 at the Marriot Marquis in New York, NY.

About Personalis, Inc.

At Personalis, we are transforming the active management of cancer through breakthrough personalized testing. We aim to drive a new paradigm for cancer management, guiding care throughout the patient journey. Our highly sensitive assays combine tumor-and-normal profiling with proprietary algorithms to deliver advanced insights even as cancer evolves over time. Our products are designed to detect minimal residual disease (MRD) and recurrence at the earliest timepoints, enable selection of targeted therapies based on ultra-comprehensive genomic profiling, and enhance biomarker strategy for drug development. Personalis is based in Fremont, California. To learn more, visit www.personalis.com and connect with us on LinkedIn and X (Twitter).

View source version on businesswire.com: https://www.businesswire.com/news/home/20260514901225/en/

Investor Relations:
Caroline Corner
[email protected]
415-202-5678

Media:
[email protected]

Source: Personalis, Inc.

You May Also Be Interested In

• First Internet Bancorp to Participate in the KBW Fintech Ecosystem Conference
• Kimball Electronics Reports Q1 Results Highlighted by the Return to Top-Line Growth; Company Reiterates Guidance for Fiscal 2027 With Sales Expected at the High End of the Range
• Pursuit Reports Record Third Quarter 2026 Results and Reaffirms Full Year Adjusted EBITDA Guidance Midpoint